AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox

News Highlights
There have been no significant news developments reported recently for IperionX. Investors should monitor upcoming announcements for potential catalysts or triggers for price movement.
Analyst Views & Fundamentals
Recent analyst activity shows a Strong Buy rating from Roth Capital analyst Joe Reagor, who has a perfect 100.0% historical win rate and an average return of 6.07%. However, this positive signal is at odds with the stock’s current sharp price decline. Average Rating (Simple Mean): 5.00 Weighted Rating (Performance-Weighted): 5.49 Ratings Consistency: There are differences among market participants, with current price movement falling out of alignment with expectations. Price Trend Mismatch: The current price is down by 17.57%, which does not align with the optimistic market expectations.
Key Fundamental Factors:
Price-to-Sales (PS): 1333.75 (internal diagnostic score: 0.00)
Profit-Market Value (Profit-MV): 0.97% (internal diagnostic score: 2.92)
Net Income-to-Revenue: -10.13% (internal diagnostic score: 1.68)
Return on Assets (ROA): -33.65% (internal diagnostic score: 0.00)
Gross Margin (GMAR): 22.75% (internal diagnostic score: 2.22)
Cash-to-UP: -7.81% (internal diagnostic score: 2.51)
Return on Equity (ROE): -38.24% (internal diagnostic score: 0.22)
Cash Flow from Operations (CFOA): -20.75% (internal diagnostic score: 0.04)
Net Profit Margin (NPM): -4104.93% (internal diagnostic score: 2.03)
Asset-to-Market Value (Asset-MV): -1.78% (internal diagnostic score: 2.54)
Overall, while a few metrics (GMAR, Profit-MV) show mild potential, most fundamentals suggest significant underperformance.
Money-Flow Trends
IperionX is currently seeing negative money-flow across all size categories:
Small investors: 47.68% inflow ratio
Medium investors: 47.89% inflow ratio
Large investors: 49.52% inflow ratio
Extra-large investors: 46.45% inflow ratio
These figures indicate a lack of conviction in the stock’s near-term prospects, with inflows trending lower across the board. The fund-flow score is 7.5 (good), suggesting moderate optimism among big-money players, though the overall trend remains bearish.
Key Technical Signals
IperionX’s technical indicators are overwhelmingly bearish, with no bullish signals in the last five days:
Long Lower Shadow: internal diagnostic score 2.83 (neutral rise), observed on 2025-11-18
WR Oversold: internal diagnostic score 1.00 (biased bearish), observed on multiple dates including 2025-11-07, 2025-11-18, and 2025-11-17
Marubozu White: internal diagnostic score 6.06 (neutral rise), observed on 2025-11-07 and 2025-11-17
RSI Oversold: internal diagnostic score 1.00 (biased bearish), observed repeatedly from 2025-11-07 to 2025-11-18
Key Insights: Technical momentum is weak, with 3 bearish indicators versus 0 bullish ones. Investors are warned to watch for further declines, especially in light of the recent oversold conditions which historically correlate with poor returns.
Conclusion
Consider avoiding IperionX for now. The stock is currently exhibiting poor technical signals, negative money-flow across all investor sizes, and weak fundamentals. Analysts remain optimistic, but their signals are divergent and misaligned with the price trend. Investors may want to wait for a potential rebound or better alignment of technical and fundamental signals before entering a position.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet